Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2009 2
2011 1
2012 2
2013 2
2014 8
2015 2
2016 2
2017 2
2018 4
2019 3
2020 2
2021 6
2022 2
2023 9
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

45 results

Results by year

Filters applied: . Clear all
Page 1
Tools for a personalized tacrolimus dose adjustment in the follow-up of renal transplant recipients. Metabolizing phenotype according to CYP3A genetic polymorphisms versus concentration-dose ratio.
Vidal-Alabró A, Colom H, Fontova P, Cerezo G, Melilli E, Montero N, Coloma A, Manonelles A, Favà A, Cruzado JM, Torras J, Grinyó JM, Lloberas N. Vidal-Alabró A, et al. Among authors: colom h. Nefrologia (Engl Ed). 2024 Mar-Apr;44(2):204-216. doi: 10.1016/j.nefroe.2024.03.019. Epub 2024 Apr 12. Nefrologia (Engl Ed). 2024. PMID: 38614890 Free article.
The Effect of Polymorphisms and Other Biomarkers on Infliximab Exposure in Paediatric Inflammatory Bowel Disease: Development of a Population Pharmacokinetic Model.
Clemente-Bautista S, Trocóniz IF, Segarra-Cantón Ó, Salvador-Marín S, Parramón-Teixidó CJ, Álvarez-Beltrán M, López-Fernández LA, Colom H, Cabañas-Poy MJ, Gorgas-Torner MQ, Miarons M. Clemente-Bautista S, et al. Among authors: colom h. Paediatr Drugs. 2024 Mar 20. doi: 10.1007/s40272-024-00621-1. Online ahead of print. Paediatr Drugs. 2024. PMID: 38507036
Voriconazole Pharmacokinetics in Critically Ill Patients and Extracorporeal Membrane Oxygenation Support: A Retrospective Comparative Case-Control Study.
Ronda M, Llop-Talaveron JM, Fuset M, Leiva E, Shaw E, Gumucio-Sanguino VD, Diez Y, Colom H, Rigo-Bonnin R, Puig-Asensio M, Carratalà J, Padullés A. Ronda M, et al. Among authors: colom h. Antibiotics (Basel). 2023 Jun 25;12(7):1100. doi: 10.3390/antibiotics12071100. Antibiotics (Basel). 2023. PMID: 37508196 Free PMC article.
A prospective controlled, randomized clinical trial of kidney transplant recipients developed personalized tacrolimus dosing using model-based Bayesian Prediction.
Lloberas N, Grinyó JM, Colom H, Vidal-Alabró A, Fontova P, Rigo-Bonnin R, Padró A, Bestard O, Melilli E, Montero N, Coloma A, Manonelles A, Meneghini M, Favà A, Torras J, Cruzado JM. Lloberas N, et al. Among authors: colom h. Kidney Int. 2023 Oct;104(4):840-850. doi: 10.1016/j.kint.2023.06.021. Epub 2023 Jun 28. Kidney Int. 2023. PMID: 37391040 Clinical Trial.
In Vitro Approaches to Explore the Anticancer Potential of One Natural Flavanone and Four Derivatives Loaded in Biopolymeric Nanoparticles for Application in Topical Delivery Treatments.
Bustos-Salgado P, Andrade-Carrera B, Domínguez-Villegas V, Noé V, Mallandrich M, Colom H, Calpena-Campmany A, Garduño-Ramírez ML. Bustos-Salgado P, et al. Among authors: colom h. Pharmaceutics. 2023 May 31;15(6):1632. doi: 10.3390/pharmaceutics15061632. Pharmaceutics. 2023. PMID: 37376079 Free PMC article.
The Effect of Intracellular Tacrolimus Exposure on Calcineurin Inhibition in Immediate- and Extended-Release Tacrolimus Formulations.
Fontova P, van Merendonk LN, Vidal-Alabró A, Rigo-Bonnin R, Cerezo G, van Oevelen S, Bestard O, Melilli E, Montero N, Coloma A, Manonelles A, Torras J, Cruzado JM, Grinyó JM, Colom H, Lloberas N. Fontova P, et al. Among authors: colom h. Pharmaceutics. 2023 May 12;15(5):1481. doi: 10.3390/pharmaceutics15051481. Pharmaceutics. 2023. PMID: 37242723 Free PMC article.
45 results